COMMUNIQUÉS West-GlobeNewswire

Information from Infant Bacterial Therapeutics Capital Markets Day 2017

08/09/2017 - 14:33

Infant Bacterial Therapeutics has today, September 8, 2017, hosted a Capital Markets Day for investors, financial analysts and media in Stockholm. The purpose of the Capital Markets Day was to present Infant Bacterial [...]

Inivata: Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer

08/09/2017 - 13:30

Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer Research Triangle Park, NC and Cambridge, UK, September 8, 2017 -- Inivata , a global clinical cancer genomics company utilizing an industry- [...]

Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon

08/09/2017 - 13:00

Clinically-Proven, Durable, Consistent, and Safe Market-Leading DCB Poised to Improve Outcomes for PAD Patients in Japan DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral [...]

Nicox : Informations financières et point des activités du premier semestre 2017

08/09/2017 - 07:30

Communiqué de presse Nicox : Informations financières et point des activités du premier semestre 2017 Approbation de la demande d'autorisation de mise sur le marché ( New Drug Application , NDA) de ZERVIATE TM (solution [...]

Nicox first half 2017 business and financial update

08/09/2017 - 07:30

Press Release Nicox first half 2017 business and financial update ZERVIATE TM (cetirizine ophthalmic solution), 0.24% New Drug Application (NDA) approved Investigational New Drug (IND) submissions for NCX 470 for IOP [...]

Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma

08/09/2017 - 06:58

Sanofi and Regeneron Announce That Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Paris, France and Tarrytown, New York - September 8, 2017 - [...]

Sanofi et Regeneron annoncent que la FDA a accordé la désignation de « Découverte capitale » au cemiplimab (REGN2810) dans le traitement du carcinome épidermoïde cutané au stade avancé

08/09/2017 - 06:58

Sanofi et Regeneron annoncent que la FDA a accordé la désignation de « Découverte capitale » au cemiplimab (REGN2810) dans le traitement du carcinome épidermoïde cutané au stade avancé Paris (France) et Tarrytown (New [...]

Novartis presents new analysis demonstrating AMG 334 (erenumab) significantly reduced monthly migraine days in patients who failed previous preventive therapies

07/09/2017 - 22:30

AMG 334 (erenumab) delivered consistent reductions in monthly migraine days for patients with chronic migraine and prior treatment failure, a population with significant unmet need Dedicated cardiovascular safety study [...]

LifeVantage Corporation Increases Global Footprint with Expansion into Germany

07/09/2017 - 22:05

Products available in Germany include Protandim® Nrf2 Synergizer and the company's TrueScience® Anti-Aging Skin Care Regimen SALT LAKE CITY, Sept. 07, 2017 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), [...]

XBiotech annonce la présentation des données de l'étude de phase 2 pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée

07/09/2017 - 21:54

Résultats de l'étude de phase 2 randomisée pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée AUSTIN, Texas, le 7 septembre 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd' [...]

The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer

07/09/2017 - 20:16

Groundbreaking research will shed light on the newest advances in the study of lung cancer DENVER, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today [...]

Inivata: Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network

07/09/2017 - 18:33

Inivata Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network This network will bring together global leaders in cancer care to unlock the potential of [...]

SPINEWAY : Poursuite du déploiement aux USA Nouveau distributeur au Texas

07/09/2017 - 17:50

Communiqué de presse Ecully, le 7 septembre 2017 Poursuite du déploiement aux USA Nouveau distributeur au Texas Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la [...]

SPINEWAY : Continued expansion in the USA New distributor in Texas

07/09/2017 - 17:50

Press release Ecully, 7 September 2017 Continued expansion in the USA New distributor in Texas Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just [...]

ThromboGenics Business Update - H1 2017

07/09/2017 - 17:40

Press release 7 September, 2017 Regulated Information Good Progress in Advancing Diabetic Eye Disease Portfolio Oncurious NV grows pipeline with 5 immuno-oncology assets from VIB Cash Position - €65.1 Million end H1 [...]

Medtronic Chairman and CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference

07/09/2017 - 17:00

DUBLIN - September 7, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare Conference on Monday, [...]

Arix Bioscience plc notes positive trial data from Verona Pharma in COPD

07/09/2017 - 15:05

Arix Bioscience plc notes positive trial data from Verona Pharma in COPD LONDON, 7 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science company supporting medical [...]

Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress

07/09/2017 - 14:00

Treating COPD and Asthma with Targeted Lung Denervation is Focus of Mini-Symposium MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira , a developer of medical devices to treat obstructive lung diseases, today [...]

XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa

07/09/2017 - 14:00

Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurati AUSTIN, Texas, Sept. 07, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from the [...]